The long-term reproducibility and scientific validity of international biomedical research is experiencing a massive quality upgrade driven by the rapid commercialization of recombinant custom antibody expression platforms. According to extensive research assessments within the Monoclonal Antibody Custom Service Market, the scientific community has historically grappled with a widespread...